Filing Details
- Accession Number:
- 0001181431-11-025300
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-25 20:07:37
- Reporting Period:
- 2011-04-20
- Filing Date:
- 2011-04-25
- Accepted Time:
- 2011-04-25 20:07:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369786 | Sagent Holding Co. | SGNT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227255 | Frank Kung | C/O Sagent Pharmaceuticals, Inc. 1901 North Roselle Road, Suite 700 Schaumburg IL 60195 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-04-20 | 20,000 | $16.00 | 26,379 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 8,961,452 | Indirect | See Footnote |
Footnotes
- The shares reported are held of record collectively by Vivo Ventures Fund V, L.P., Vivo Ventures V Affiliates Fund, L.P., Vivo Ventures Fund VI, L.P. and Vivo Ventures VI Affiliates Fund, L.P. (the "Vivo Funds"). Dr. Kung is the managing partner of Vivo Ventures. As a result, Dr. Kung may be deemed the beneficial owner of the shares of common stock owned collectively by the Vivo Funds. Dr. Kung hereby disclaims any beneficial ownership of any shares directly held by the Vivo Funds, except to the extent of his pecuniary interest therein.